Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 39-44

  Chung, Tze Wen ^a   Lin, Shyr Yi ^d   Liu, Der Zen ^b   Tyan, Yu Chang ^c   Yang, Juin Sen ^a  

^a NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 FU; Drug delivery; Hydrogels; Interpenetrating CS network; Poloxamer

Indexed keywords

CHITOSAN; FLUOROURACIL; GLUTARALDEHYDE; POLOXAMER; WATER;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DIFFUSION; DRUG DELIVERY SYSTEM; GEL; HEAT SENSITIVITY; IN VITRO STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VISCOSITY;

ANTIMETABOLITES, ANTINEOPLASTIC; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG CARRIERS; DRUG COMPOUNDING; FLUOROURACIL; GELS; GLUTARAL; KINETICS; MODELS, CHEMICAL; MOLECULAR CONFORMATION; POLOXAMER; SOLUBILITY; TEMPERATURE; VISCOSITY;

EID: 70350347757     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.035     Document Type: Article

References (28)

1. Amiji M.M., Lai P.K., Shenoy D.B., and Rao M. Intratumoral administration of Paclitaxel in an in-situ gelling Poloxamer 407 formulation. Pharm. Dev. Technol. 7 (2002) 195-202
2. Barichello J.M., Morishita M., and Nagai K.T.T. Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm. 184 (1999) 189-198
3. Caffaggi S., Russo E., Cavigliolli G., Parodi B., Stefani R., Sillo G., Leardi R., and Bignardi G. Poloxamer as a solubilising agent for tolfenamic acid and as a base for a gel formation. Eur. J. Pharm. Sci. 35 (2008) 19-29
4. Cho K.Y., Chung T.W., Kim B.C., Kim M.K., Lee J.H., Wee W.R., and Chob C.S. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int. J. Pharm. 260 (2003) 83-91
5. ® grafted chitosan copolymer as a novel injectable biomaterial. Curr. Appl. Phys. 5 (2005) 485-488
6. Chung T.W., Wang S.S., and Tsaia W.J. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nano-particles. Biomaterials 29 (2008) 228-237
7. Dumortier G., Grossiord J.L., Agnely F., and Chaumeil J.C. A review of Poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23 (2006) 12-25
8. El-Sherbiny I.M., Lins R.J., Abdel-Bary E.M., and Harding D.R.K. Preparation, characterization, swelling and in vitro drug release behaviour of poly [N-acryl-oylglycine-chitosan] interpolymeric pH and thermally-responsive hydrogels. Eur. Polym. J. 41 (2005) 2584-2591
9. Jeong B., Kim S.W., and Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliver. Rev. 54 (2002) 37-51
10. Johnson K.R., Young K.K., and Fan W. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy. Clin. Cancer Res. 5 (1999) 2559-2565
11. Juhasz J., Lenaerts V., Raymond P., and Ong H. Diffusion of rat atrial natriuretic factor in thermo-reversible poloxamer gels. Biomaterials 10 (1989) 265-268
12. Kumar M.N.V.R., Bakowsky U., and Lehr C.M. Preparation and characterization of cationic PLGA nano-spheres as DNA carriers. Biomaterials 25 (2004) 1771-1777
13. In: Lanza R.P., Langer R., and Vancanti J. (Eds). Principles of Tissue Engineering. 2nd ed. (2000), Academic Press, San Diego, CA, USA
14. Lin H.R., and Sung K.C. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J. Contr. Rel. 29 (2000) 379-388
15. Lin Y., Chen Q., and Luo H. Preparation and characterization of N-(2-carboxybenzyl) chitosan as a potential pH-sensitive hydrogel for drug delivery. Carbohydr. Res. 342 (2007) 87-95
16. Liu D.Z., Chen W.P., Lee C.P., Wang Y.C., Wu S.L., and Chung T.W. Effects of alginate coated on the characteristics of tetracycline loaded PLGA microspheres to periodontal pocket. J. Microencapsul. 21 (2004) 643-652
17. Liu T., and Chu B. Formation of homogeneous gel-like phases by mixed triblock copolymer micelles in aqueous solution: FCC to BCC phase transition. J. Appl. Cryst. 33 (2000) 727-730
18. Peppas N.A., Gurny R., Doelker E., and Buri P. Modelling of drug diffusion through swellable systems. J. Membr. Sci. 7 (1980) 241-253
19. Ricci E.J., Lunardi L.O., Nanclares D.M.A., and Marchettia M. Sustained release of lidocaine from Poloxamer 407 gels. Int. J. Pharm. 288 (2005) 235-244
20. Ritger P.L., and Peppas N.A. A Simple equation for description of solute release. I. Fickian and non-Fickian release from swellable devices. J. Contr. Rel. 5 (1987) 37-42
21. Roques C., Salmon A., Fiszman M.Y., Fattal E., and Fromes Y. Intrapericardial administration of novel DNA formulations based on thermosensitive Poloxamer 407 gel. Int. J. Pharm. 331 (2007) 220-223
22. Ruel-Gariepy E., and Leroux J.C. In situ-forming hydrogels-review of temperature-sensitive system. Eur. J. Pharm. Biopharm. 58 (2006) 409-426
23. Sastre R.L., Oimo R., Teijon C., Muniz E., Teijon J.M., and Blanco M.D. 5-Fluorouracil plasma levels and biodegradation of subcutaneous injected drug-loaded microspheres prepared by spray-drying poly(d,l)LA and PLGA polymers. Inter. J. Pharm. 338 (2007) 180-190
24. Singh B., and Chauhan N. Preliminary evaluation of molecular imprinting of 5-fluorouracil within hydrogels for use as drug delivery systems. Acta Biomater. 4 (2008) 1244-1254
25. Sosnik A., and Cohn D. Ethoxysilane-capped PEO-PPO-PEO triblocks: a new family of reverse thermo-responsive polymers. Biomaterials 25 (2004) 2851-2858
26. Tas-delen B., Kayaman-Apohan N., Guven O., and Baysal B.M. Anticancer drug release from poly (N-isopropylacrylamide/itaconic acid) copolymeric hydrogels. Rad. Phys. Chem. 73 (2005) 340-345
27. Wang S.S., Yang M.G., and Chung T.W. Liposomes/chitosan scaffold/human fibrin gel composite systems for delivering hydrophilic drugs-release behaviors of Tirofiban in vitro. Drug Delivery 15 (2008) 149-157
28. Yoneda K., Yamamoto T., Ueta E., and Osaki T. The inhibitory action of BOF-A2, a 5-fluorouracil derivative, on squamous cell carcinoma. Cancer Lett. 137 (1999) 17-25